Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 8Phase 3 4Phase 1/2 1Phase 1 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4Liver Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Embolization, Therapeutic × Clear all
NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Sun Yat-sen University

Phase 3 Completed
315 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04803019 2021-03-19

RAD-18-TAcE

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 3 Unknown
154 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03791918 2019-05-02

Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria

Sun Yat-sen University

Phase 3 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT01229839 2019-03-06

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Sun Yat-sen University

Phase 3 Completed
668 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡